Substituted tetrahydropyridine derivatives acting on 5-HT receptors

PCT No. PCT/GB96/02763 Sec. 371 Date Apr. 29, 1998 Sec. 102(e) Date Apr. 29, 1998 PCT Filed Nov. 13, 1996 PCT Pub. No. WO97/18204 PCT Pub. Date May 22, 1997Compounds having formula I, or salts or prodrugs thereof: are selective agonists of the 5-HT1D alpha receptor and are useful in the treatment of...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: SHOWELL, GRAHAM ANDREW, MACLEOD, ANGUS MURRAY, BOURRAIN, SYLVIE
Format: Patent
Sprache:eng
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator SHOWELL
GRAHAM ANDREW
MACLEOD
ANGUS MURRAY
BOURRAIN
SYLVIE
description PCT No. PCT/GB96/02763 Sec. 371 Date Apr. 29, 1998 Sec. 102(e) Date Apr. 29, 1998 PCT Filed Nov. 13, 1996 PCT Pub. No. WO97/18204 PCT Pub. Date May 22, 1997Compounds having formula I, or salts or prodrugs thereof: are selective agonists of the 5-HT1D alpha receptor and are useful in the treatment of migraine and associated conditions.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_US6054469A</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>US6054469A</sourcerecordid><originalsourceid>FETCH-epo_espacenet_US6054469A3</originalsourceid><addsrcrecordid>eNqFyrEKwjAQBuAsDlJ9Bu8FCgXbgqMUpXvrXGLyaw8kCZdroW_v4u70Ld_edMPyzMq6KDwpVOy8eYlpE_YcQB7Cq1Vekck65fCmGKgp-5EEDkmj5IPZvewn4_izMKf7bez6EilOyMk6BOj0GNqqqev2cj3_H18fqjJw</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Substituted tetrahydropyridine derivatives acting on 5-HT receptors</title><source>esp@cenet</source><creator>SHOWELL; GRAHAM ANDREW ; MACLEOD; ANGUS MURRAY ; BOURRAIN; SYLVIE</creator><creatorcontrib>SHOWELL; GRAHAM ANDREW ; MACLEOD; ANGUS MURRAY ; BOURRAIN; SYLVIE</creatorcontrib><description>PCT No. PCT/GB96/02763 Sec. 371 Date Apr. 29, 1998 Sec. 102(e) Date Apr. 29, 1998 PCT Filed Nov. 13, 1996 PCT Pub. No. WO97/18204 PCT Pub. Date May 22, 1997Compounds having formula I, or salts or prodrugs thereof: are selective agonists of the 5-HT1D alpha receptor and are useful in the treatment of migraine and associated conditions.</description><edition>7</edition><language>eng</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2000</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20000425&amp;DB=EPODOC&amp;CC=US&amp;NR=6054469A$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25542,76290</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20000425&amp;DB=EPODOC&amp;CC=US&amp;NR=6054469A$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>SHOWELL; GRAHAM ANDREW</creatorcontrib><creatorcontrib>MACLEOD; ANGUS MURRAY</creatorcontrib><creatorcontrib>BOURRAIN; SYLVIE</creatorcontrib><title>Substituted tetrahydropyridine derivatives acting on 5-HT receptors</title><description>PCT No. PCT/GB96/02763 Sec. 371 Date Apr. 29, 1998 Sec. 102(e) Date Apr. 29, 1998 PCT Filed Nov. 13, 1996 PCT Pub. No. WO97/18204 PCT Pub. Date May 22, 1997Compounds having formula I, or salts or prodrugs thereof: are selective agonists of the 5-HT1D alpha receptor and are useful in the treatment of migraine and associated conditions.</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2000</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqFyrEKwjAQBuAsDlJ9Bu8FCgXbgqMUpXvrXGLyaw8kCZdroW_v4u70Ld_edMPyzMq6KDwpVOy8eYlpE_YcQB7Cq1Vekck65fCmGKgp-5EEDkmj5IPZvewn4_izMKf7bez6EilOyMk6BOj0GNqqqev2cj3_H18fqjJw</recordid><startdate>20000425</startdate><enddate>20000425</enddate><creator>SHOWELL; GRAHAM ANDREW</creator><creator>MACLEOD; ANGUS MURRAY</creator><creator>BOURRAIN; SYLVIE</creator><scope>EVB</scope></search><sort><creationdate>20000425</creationdate><title>Substituted tetrahydropyridine derivatives acting on 5-HT receptors</title><author>SHOWELL; GRAHAM ANDREW ; MACLEOD; ANGUS MURRAY ; BOURRAIN; SYLVIE</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_US6054469A3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2000</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>SHOWELL; GRAHAM ANDREW</creatorcontrib><creatorcontrib>MACLEOD; ANGUS MURRAY</creatorcontrib><creatorcontrib>BOURRAIN; SYLVIE</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>SHOWELL; GRAHAM ANDREW</au><au>MACLEOD; ANGUS MURRAY</au><au>BOURRAIN; SYLVIE</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Substituted tetrahydropyridine derivatives acting on 5-HT receptors</title><date>2000-04-25</date><risdate>2000</risdate><abstract>PCT No. PCT/GB96/02763 Sec. 371 Date Apr. 29, 1998 Sec. 102(e) Date Apr. 29, 1998 PCT Filed Nov. 13, 1996 PCT Pub. No. WO97/18204 PCT Pub. Date May 22, 1997Compounds having formula I, or salts or prodrugs thereof: are selective agonists of the 5-HT1D alpha receptor and are useful in the treatment of migraine and associated conditions.</abstract><edition>7</edition><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng
recordid cdi_epo_espacenet_US6054469A
source esp@cenet
subjects CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
title Substituted tetrahydropyridine derivatives acting on 5-HT receptors
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-02T09%3A31%3A19IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=SHOWELL;%20GRAHAM%20ANDREW&rft.date=2000-04-25&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EUS6054469A%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true